Clinical Trials Sponsored by Ming Chan

Total 4683 results

Medtronic - MITG

Completed

AbsorbaTack Evaluation of Postoperative Pain Following Laparoscopic Hernia Repair

Hernia, Inguinal | Hernia, Ventral

United States
Medtronic - MITG

Completed

Safety and Performance of the Covidien EEA Hemorrhoid and Prolapse Stapling Set in a Hemorrhoidopexy Procedure

Hemorrhoid

United States
Medtronic - MITG

Completed

Neuroendocrine Brake for Type 2 Diabetes Mellitus

Diabetes

Brazil
Medtronic - MITG

Completed

Oxygen Saturation Alarms in the Neonatal Intensive Care Unit

Hypoxemia

United States
Medtronic - MITG

Completed

A Multi-Center Study to Assess the Performance of Saturation Patterns.

Obstructive Sleep Apnea | Sleep Apnea | Sleep-Disordered Breathing | Central Sleep Apnea

United States
Medtronic - MITG

Completed

Oxygen Saturation Monitoring During Surgery

Sleep Apnea, Obstructive

United States
Medtronic - MITG

Completed

Comparison of the Hemostatic Patch to Fibrin Sealant (TachoSil®) in Subjects Undergoing Hepatic Surgery

Liver Disease

Belgium, Austria, Germany
Medtronic - MITG

Completed

Pulse Oximetry- Evaluating Resp Rate- PCBA-1

Healthy Subjects

United States
Medtronic - MITG

Completed

Pulse Oximetry_Performance Testing- PCBA-1 (Printed Circuit Board Assembly) NEO/PEDS

Subjects With an Existing Intra-arterial Line

United States
Medtronic - MITG

Completed

Pulse Oximetry_Performance During Severe Signal Interference - PCBA-1 (Printed Circuit Board Assembly)

Healthy

United States
Medtronic - MITG

Completed

Respiration Rate Monitoring During Transitions

Focus of the Study is Measuring Respiratory Rate

United States
Medtronic - MITG

Completed

CARE--Childhood Awareness and Recall Evaluation

Anesthesia

United States
Medtronic - MITG

Completed

ADVANCE: Assessment for Defining Variability in Anesthesia Through Novel Clinical EEG (CVI)

Pain

United States, Spain
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

A Phase 1, Single-arm, Open-label, Dose-escalation Study of JWATM204 as T Cell-targeted Immunotherapy in the Treatment Amongst Subjects With Advanced Hepatocellular Carcinoma

Liver Carcinoma | Hepatic Cell Carcinoma

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

Relmacabtagene Autoleucel in Patients With LBCL

Large B-cell Lymphoma

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Mantle Cell Lymphoma

Mantle Cell Lymphoma

China
Ming Zhao

Recruiting

Ablation Plus Tislelizumab Versus Ablation Alone for Intrahepatic Recurrent Early Stage HCC

Recurrent Hepatocellular Carcinoma

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Non-Hodgkins Lymphoma

Lymphoma, Non-Hodgkin | Follicular Lymphoma | Diffuse Large B Cell Lymphoma

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Completed

CD19-targeted CAR T Cells （JWCAR029） for Primary Refractory Diffuse Large B Cell Lymphoma

Diffuse Large B Cell Lymphoma

China
Shi Ming

Completed

HAIC Plus Lenvatinib and Toripalimab for Advanced HCC

Hepatocellular Carcinoma

China
Shi Ming

Withdrawn

Lenvatinib Plus PD-1 Antibody for Intermediate-stage HCC Beyond Up-to-seven Criteria

Hepatocellular Carcinoma

China
Ming Kuang

Unknown

Preoperative Prediction of Microvascular Invasion in Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
Ming Kuang

Unknown

Preoperative Estimation of Microvascular Invasion in Hepatocellular Carcinoma

Hepatocellular Carcinoma
Ming Kuang
Sun Yat-sen University

Unknown

Medical Education Intervention for Medical Students

Mental Health
Ming-Chyi Huang

Unknown

The Efficacy of A Smartphone-based Support System to Reinforce Alcohol Abstinence in Treatment-seeking Patients

Alcohol Dependence

Taiwan
Xiao-Ming Mao

Completed

Prevention Relapse of Graves' Disease by Intrathyroid Injection of Dexamethasone

Graves' Disease
Shanghai Ming Ju Biotechnology Co., Ltd.

Not yet recruiting

Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus
Shanghai Ming Ju Biotechnology Co., Ltd.

Not yet recruiting

Relmacabtagene Autoleucel as Second-Line Therapy in Adult Patients With Aggressive B-cell NHL

Lymphoma, Large B-Cell, Diffuse | High-grade B-cell Lymphoma | Follicular Lymphoma Grade 3B | Mediastinal B-Cell Diffuse Large Cell Lymphoma

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

China
Ming Zhao

Unknown

Combine TACE and RFA Versus TACE Alone for HCC With PVTT (CORTT)

Hepatocellular Carcinoma

China
Ming Kuang

Unknown

RFA+Highly-purified CTL vs. RFA Alone for Recurrent HCC

Hepatocellular Carcinoma

China
Xiao-Ming Mao

Completed

Function of Regulatory T Cells Improved by Dexamethasone in Graves' Patients

Graves' Disease

China
Meng Chao Hepatobiliary Hospital of Fujian Medical...
Suzhou Suncadia Biopharmaceuticals Co., Ltd.

Recruiting

A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma

Hepatocellular Carcinoma

China
National Yang Ming Chiao Tung University

Not yet recruiting

Effectiveness of a Combined Diet and Mindfulness Program on Weight Loss in Breast Cancer Survivors

Breast Cancer | Weight Loss

Taiwan
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

CD19-targeted CAR T Cells for Relapsed and Refractory (R/R) Large B-cell Lymphoma

Lymphoma, Non-Hodgkin | Diffuse Large B Cell Lymphoma

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Not yet recruiting

Relmacabtagene Autoleucel in Hematologic Malignancies

Lymphoma, B-Cell | Follicular Lymphoma | Large B-cell Lymphoma

China
Shanghai Ming Ju Biotechnology Co., Ltd.

Recruiting

CD19-targeted CAR T Cells for Patients With Relapsed or Refractory in B-cell Acute Lymphoblastic Leukemia

Acute Lymphocytic Leukemia

China
Shi Ming

Recruiting

HAIC With FOLFOX Versus Systemic Chemotherapy With GP for Unresectable ICC

Intrahepatic Cholangiocarcinoma

China
Ming Zhao

Recruiting

TACE+RFA Versus TACE Alone for Intermediate-stage Hepatocellular Carcinoma

Hepatocellular Carcinoma | Chemoembolization, Therapeutic | Ablation Techniques, RFA

China
Shi Ming

Withdrawn

Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T

Hepatocellular Carcinoma

China
Ming-Yuan Chih

Completed

Physical Activity Monitoring Among BMT Patients

Bone Marrow Transplantation

United States
Yawei Cheng

Completed

Autism, Emotional Processing, and the Amygdala

Autism Spectrum Disorder
Shi Ming

Unknown

HAIC Versus Systemic Chemotherapy for Unresectable ICC

Intrahepatic Cholangiocarcinoma

China
Ming Zhao

Approved for marketing

HAIC Using Oxaliplatin Plus Fluorouracil/Leucovorin for Patients With Locally Advanced HCC

Hepatocellular Carcinoma | Injury; Blood Vessel, Hepatic, Artery

China
Shi Ming

Suspended

Lenvatinib Plus PD-1 Antibody for Unresectable ICC

Intrahepatic Cholangiocarcinoma

China
Chin-Jung Wang
National Health Research Institutes, Taiwan

Unknown

Clinical Test of the MRgHIFU System on Uterine Fibroids (MRgHIFU)

Uterine Fibroids

Taiwan
Po-Lin Chen, MD
Grape King Bio Ltd.

Completed

Probiotics for Liver Cirrhosis With Portal Hypertension

Liver Cirrhosis | Portal Hypertension

Taiwan
Sally CHAN

Completed

Digital Buddy : Digital Inclusion for the Elderly

Mental Wellbeing of Older Adults

Hong Kong
King Saud University
King Saud Medical City

Completed

The Effect of Caffeine on the Narcoleptic Patients

Narcolepsy

Saudi Arabia
King Saud University
King Fahad Medical City

Completed

The Use of Inhaled Corticosteroids in the Treatment of Asthma is Children in the Emergency Room

Status Asthmaticus

Saudi Arabia

Clinical Trials Sponsored by Ming Chan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Singapore

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations